Audited annual filings, TTM ratios and consensus forward estimates
Wall Street price targets and rating actions
Revenue disaggregation per 10-K filing
Annual filings (FY) with consensus forward estimates (hatched)
1255 daily bars · split adjusted
Daily · Wilder smoothing
Classic floor pivots from 2026-10-19
Computed from daily OHLCV bars
| Indicator | Value | Type | Action |
|---|---|---|---|
| RSI (14) | 35.15 | Oscillator | Neutral |
| Stochastic %K (14, 3, 3) | 8.05 | Oscillator | Buy |
| Williams %R (14) | -89.87 | Oscillator | Buy |
| MACD (12, 26, 9) | -7.64 (Hist -7.14) | Oscillator | Strong Sell |
| Average Directional Index (14) | 19.20 (+DI 18.3 / -DI 35.5) | Trend | Neutral |
Free float vs. closely held shares
13F institutional holdings are not available in the current data plan.
SEC Form 4 filings
| Date | Insider | Role | Type | Shares @ price | Value |
|---|---|---|---|---|---|
| Sep 9, 26 | Archer Timothy | officer: President and CEO | M-Exempt | 30,000 @ $30.03 | $901.0K |
FY2026 · 10-K disclosure
FY2026 · 10-K disclosure
| EMA 20 | 302.64 | MA | Strong Sell |
| SMA 20 | 312.74 | MA | Strong Sell |
| EMA 50 | 307.90 | MA | Strong Sell |
| SMA 50 | 308.32 | MA | Strong Sell |
| SMA 200 | 282.46 | MA | Strong Sell |
| Sep 9, 26 |
| Archer Timothy |
| officer: President and CEO |
| S-Sale |
| 30,000 @ $319.26 |
| $9.58M |
| Sep 9, 26 | Archer Timothy | officer: President and CEO | M-Exempt | 30,000 @ $30.03 | $901.0K |
| Sep 9, 26 | Mayer Bethany | director | S-Sale | 9,557 @ $314.74 | $3.01M |
| Sep 2, 26 | Varadarajan Seshasayee | officer: Senior Vice President | M-Exempt | 27,480 @ $30.03 | $825.3K |
| Sep 2, 26 | Varadarajan Seshasayee | officer: Senior Vice President | M-Exempt | 12,270 @ $59.88 | $734.7K |
| Sep 2, 26 | Varadarajan Seshasayee | officer: Senior Vice President | S-Sale | 12,270 @ $291.32 | $3.57M |
| Sep 2, 26 | Varadarajan Seshasayee | officer: Senior Vice President | S-Sale | 27,480 @ $291.32 | $8.01M |
Stock news · updated daily
Applied Materials and Lam Research are benefiting from AI-driven chip demand, but stronger memory growth and customer support momentum give LRCX an edge.
Both NVIDIA and Lam Research benefit from the AI boom, but NVIDIA's faster growth, stronger margins and lower valuation give it an edge. Here's why.
The Carillon Eagle Growth & Income Fund lagged its S&P 500 benchmark during the quarter. Top securities include Microsoft, Chevron, Intercontinental Exchange, AT&T and Accenture. Bottom securities include Corning, DICK's Sporting Goods, Lam Research, Home Depot and TJX.
Brookstone Capital Management trimmed its stake in Lam Research Corporation (NASDAQ: LRCX) by 9.2% in the undefined quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 55,170 shares of the semiconductor company's stock after selling 5,565 shares during the period. Brookstone Capital Management's holdings
Axxcess Wealth Management LLC decreased its stake in shares of Lam Research Corporation (NASDAQ: LRCX) by 49.4% during the undefined quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 13,687 shares of the semiconductor company's stock after selling 13,343 shares during
Lam Research Corp. (NASDAQ:LRCX) posted upbeat first-quarter fiscal 2027 results after Wednesday's closing bell.
Lam Research (LRCX) could produce exceptional returns because of its solid growth attributes.
Lam Research TodayLRCXLam Research$232.50 -28.31 (-10.85%) As of 01:21 PM Eastern This is a fair market value price provided by Massive. Learn more.52-Week Range$135.50▼$438.50Dividend Yield0.57%P/E Ratio40.41Price Target$355.04Add to WatchlistLam Research NASDAQ: LRCX reported its fiscal first-quarter 2027 results after the close on Wednesday, Oct. 21, covering the quarter that ended in September.
Reported EPS vs. consensus estimate
| Report date | EPS est. | EPS actual | Surprise | Revenue |
|---|---|---|---|---|
| Jul 29, 2026 | 1.69 | 1.82 | Beat 7.7% | $6.72B |
| Apr 22, 2026 | 1.36 | 1.47 | Beat 8.1% | $5.84B |
| Jan 28, 2026 | 1.17 | 1.27 | Beat 8.5% | $5.34B |
| Oct 22, 2025 | 1.22 | 1.26 | Beat 3.3% | $5.32B |
| Jul 30, 2025 | 1.21 | 1.33 | Beat 9.9% | $5.17B |
| Apr 23, 2025 | 1.00 | 1.04 | Beat 4.0% | $4.72B |
SEC EDGAR filings · last 12 months
| Form | Filed | Accepted | Document |
|---|---|---|---|
| 10-Q | Oct 22, 2026 | 2026-10-22 16:07:28 | View |
| 8-K | Oct 21, 2026 | 2026-10-21 16:13:03 | View |
| ARS | Sep 24, 2026 | 2026-09-24 16:19:21 | View |
| DEFA14A | Sep 24, 2026 | 2026-09-24 16:13:35 | View |
| DEF 14A | Sep 24, 2026 | 2026-09-24 16:05:34 | View |
| 4 | Sep 10, 2026 | 2026-09-10 13:05:21 | View |
| 4 | Sep 10, 2026 | 2026-09-10 13:04:25 | View |
| 4 | Sep 3, 2026 | 2026-09-03 15:06:03 | View |
| 4 | Sep 1, 2026 | 2026-09-01 12:08:13 | View |
| 8-K | Aug 27, 2026 | 2026-08-27 17:20:05 | View |
Proxy statement (DEF 14A) disclosures
TTM vs. 5-year historical average (annual ratios)
| Metric | LRCX | Historical (5Y) / ref | Status |
|---|---|---|---|
| P/E ratio (TTM) | 47.0x | 32.6x · sector 44.2x | In line |
| Forward P/E (FY27E) | 28.6x | EPS est. 9.53 | Discount |
| Price / Book | 27.4x | 18.1x | Elevated |
| Price / Sales | 14.7x | 9.4x | Elevated |
| EV / EBITDA | 39.0x | 26.6x | Elevated |
| Return on equity | 67.0% | — | Top tier |
| Gross margin | 50.5% | 47.4% | In line |
| Debt / Equity | 0.33 | 0.56 | Conservative |
| Piotroski / Altman Z | 7/9 | Z 22.64 | Safe zone |
Discounted cash flow model
Current price $272.20
Latest analyst grade actions
| Date | Firm | Action | Previous | New grade |
|---|---|---|---|---|
| Oct 5, 26 | Morgan Stanley | maintain | Overweight | Overweight |
| Oct 1, 26 | B. Riley Securities | maintain | Buy | Buy |
| Sep 1, 26 | UBS | maintain | Buy | Buy |
| Aug 25, 26 | Mizuho | maintain | Outperform | Outperform |
| Jul 30, 26 | Wells Fargo | maintain | Overweight | Overweight |
| Jul 30, 26 | Needham | maintain | Buy | Buy |
| Jul 30, 26 | Jefferies | maintain | Buy | Buy |
| Jul 30, 26 | Morgan Stanley | maintain | Overweight | Overweight |
| Jul 30, 26 | B. Riley Securities | maintain | Buy | Buy |